Episode Details
Back to Episodes
FDA Approves First Disease-Modifying Alzheimer’s Drug | California News
Published 2 days, 11 hours ago
Description
FDA just approved Leqembi, the first new Alzheimer’s drug in decades, designed to slow cognitive decline by targeting brain plaques — offering hope but with serious risks like brain swelling and bleeding that require close monitoring.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/c40e4ff5894d1b92